Enzymes for producing non-straight-chain fatty acids
US-2015376659-A1 · Dec 31, 2015 · US
US2017191092A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017191092-A1 |
| Application number | US-201615394047-A |
| Country | US |
| Kind code | A1 |
| Filing date | Dec 29, 2016 |
| Priority date | Jul 18, 2014 |
| Publication date | Jul 6, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are genetically-modified microorganisms for producing medium chain lauric acid and/or dodecanedioic acid and methods of using the microorganisms. The microorganisms contain a nucleic acid encoding an Umbellularia californica lauroyl ACP-thioesterase (BTE) operably linked to a promoter.
Opening claim text (preview).
What is claimed is: 1 . A genetically modified microorganism, comprising a nucleic acid encoding an Umbellularia californica lauroyl ACP-thioesterase (BTE) operably linked to a promoter, wherein the microorganism produces an increased amount of medium-chain lauric acid and/or dodecanedioic acid as compared to the unmodified parent of the microorganism. 2 . The genetically modified microorganism of claim 1 , wherein the Umbellularia californica lauroyl ACP-thioesterase (BTE) is a modified Umbellularia californica lauroyl ACP-thioesterase (BTE). 3 . The genetically modified microorganism of claim 2 , wherein the modified Umbellularia californica lauroyl ACP-thioesterase (BTE) comprises residues 17-283 of a wild-type Umbellularia californica lauroyl ACP-thioesterase (BTE). 4 . The genetically modified microorganism of claim 3 , wherein the modified Umbellularia californica lauroyl ACP-thioesterase (BTE) further comprises a C-terminal His-tag fusion. 5 . The genetically modified microorganism of claim 2 , wherein the modified Umbellularia californica lauroyl ACP-thioesterase (BTE) comprises residues 17-295 of a wild-type Umbellularia californica lauroyl ACP-thioesterase (BTE). 6 . The genetically modified microorganism of claim 5 , wherein the modified Umbellularia californica lauroyl ACP-thioesterase (BTE) further comprises a C-terminal His-tag fusion. 7 . The genetically modified microorganism of claim 2 , wherein the modified Umbellularia californica lauroyl ACP-thioesterase (BTE) consists of residues 17-283 of a wild-type Umbellularia californica lauroyl ACP-thioesterase (BTE) and a C-terminal His-tag fusion. 8 . The genetically modified microorganism of claim 7 , wherein residue 124 of the wild-type Umbellularia californica lauroyl ACP-thioesterase (BTE), cysteine, is further replaced with threonine. 9 . The genetically modified microorganism of claim 2 , wherein the modified Umbellularia californica lauroyl ACP-thioesterase (BTE) consists of residues 17-295 of a wild-type Umbellularia californica lauroyl ACP-thioesterase (BTE) and a C-terminal His-tag fusion. 10 . The genetically modified microorganism of claim 9 , wherein residue 124 of the wild-type Umbellularia californica lauroyl ACP-thioesterase (BTE), cysteine, is further replaced with threonine. 11 . The genetically modified microorganism of claim 1 , further comprising one or more additional nucleic acids each operably linked to a promoter, each additional nucleic acid encoding a protein selected from the group consisting of an acetyl-CoA carboxylase (ACC), an acetyl-CoA carboxylase carboxyl transferase subunit α (AccA), an acetyl-CoA carboxylase biotin carboxyl carrier protein (AccB), an acetyl-CoA biotin carboxylase (AccC), an acetyl-CoA carboxylase transferase subunit β (AccD), a fatty acid synthase (FAS) subunit, a cytochrome P450 reductase (CPR), a long-chain alcohol oxidase (FAO1), a long-chain alcohol dehydrogenase (FADH), and an adenosine monophosphate-forming acetyl-coenzyme A synthetase (AceCS). 12 . The genetically modified microorganism of claim 1 , further comprising additional nucleic acids each encoding a CPR, a FAO1, and a FADH, respectively. 13 . The genetically modified microorganism of claim 1 , further comprising a loss-of-function mutation in or expressing a lower level of one or more genes selected from the group consisting of a palmitoyl-acyl carrier protein (ACP) thioesterase gene, an acyl-coenzyme A oxidase gene, a citric synthetase (gltA) gene, or an acyl-coenzyme A synthetase (acs) gene. 14 . The genetically modified microorganism of claim 1 , further comprising a loss-of-function mutation in or expressing a lower level of an acyl-coenzyme A oxidase gene. 15 . The genetically modified microorganism of claim 14 , wherein the acyl-coenzyme A oxidase gene is pox2, pox5, or fadD. 16 . The genetically modified microorganism of claim 1 , wherein the microorganism (1) contains a loss-of-function mutation in or expresses a lower level of an acyl-coenzyme A oxidase gene and (2) contains additional nucleic acids each encoding a CPR, a FAO1, and a FADH, respectively. 17 . The genetically modified microorganism of claim 2 , wherein the microorganism (1) contains a loss-of-function mutation in or expresses a lower level of an acyl-coenzyme A oxidase gene and (2) contains additional nucleic acids each encoding a CPR, a FAO1, and a FADH, respectively. 18 . The genetically modified microorganism of claim 17 , wherein the acyl-coenzyme A oxidase gene is fadD. 19 . The genetically modified microorganism of claim 1 , wherein the microorganism is Yarrowia lipolytica or Escherichia coli. 20 . A method of producing a medium-chain lauric acid and/or dodecanedioic acid, the method comprising: providing the genetically-modified microorganism of claim 1 ; and culturing the microorganism in a culture medium containing glucose or glycerol at pH 6 to 8 under conditions that allow production of the medium-chain lauric acid and/or dodecanedioic acid; whereby the microorganism produces the medium-chain lauric acid and/or dodecanedioic acid.
Dodecanoyl-[acyl-carrier-protein] hydrolase (3.1.2.21) · CPC title
by hydrolysis of fatty acid esters · CPC title
acting on ester bonds (3.1) · CPC title
Fatty acids · CPC title
Polycarboxylic acids · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.